期刊文献+

自身免疫性肝炎特异性靶抗原的表达及免疫学鉴定 被引量:4

Expression and identification of specific autoantigens in autoimmune hepatitis
原文传递
导出
摘要 目的 克隆、表达可溶性肝抗原(SLA)及细胞色素P450 2D6(CYP 2D6)。方法 采用 RT—PCR技术从人肝组织poly(A)+RNA中扩增SLA及 CYP 2D6 cDNA,经BamH Ⅰ、Hind Ⅲ双酶切定向插入载体PQE-30并在大肠杆菌M15中表达。对表达载体PQE—30/SLA、PQE—30/CYP 2D6中的目的基因进行序列分析,表达产物用 SDS—PAGE、免疫印迹方法鉴定。结果 表达产物经 SDS-PACE和免疫印迹分析后在分子量 4.7 × 104和5.0 × 104处各有一条明显的蛋白带,并分别能特异性与抗SLA、CYP2D6阳性血清反应。结论 表达SLA、CYP2D6为自身免疫性肝炎的诊断及其发病机制研究提供物质基础。 Objective To express and identify soluble liver antigen (SLA) and cytochrome P-450 (CYP 2D6). Methods SLA cDNA and CYP 2D6 cDNA were obtained from human liver tissue poly (A)+RNA by RT-PCR. The cDNAs were inserted into fusion expression vector PQE-30 site of BamH I and Hind III. SLA and CYP 2D6 were identified by the SDS-PAGE and Western blot. Results SDS-PAGE analysis showed that there was a very strong stained band at about 47 kd and 50 kd, respectively. The products could specifically band to anti-SLA or anti-CYP 2D6 autoantibodies. Conclusions The clone and expression of SLA and CYP 2D6 provide usetlil substances for the diagnosis and research of pathogenesis on autoimmune hepatitis.
出处 《中华肝脏病杂志》 CAS CSCD 2002年第2期113-115,共3页 Chinese Journal of Hepatology
关键词 自身免疫性肝炎 特异性靶抗原 免疫学鉴定 可溶性肝抗原 细胞色素P4502D6 AIH Autoimmune hepatitis Soluble liver antigen Cytochrome P-450 2D6
  • 相关文献

参考文献3

  • 1Klein R,Berg PA.Glutathione S-transferase as a majorautoantigen in anti-SLA-positive autoimmune hepatitis[].Gastroenterology.1999
  • 2Manns M,Gerken G,Kyriatsoalls A,et al.Characterizationof a new subgroup of autoimmune chronic active hepatitisby autoantibodies against a soluble liver antigen[].The Lancet.1987
  • 3Wies I,Bruriner S,Henninger J,et al.Identification of tar-get antigen for SLA/LP autoantibodies in autoimmunehepatitis[].The Lancet.2000

同被引文献22

  • 1王兵.自身免疫性肝炎的研究进展[J].辽宁医学杂志,2004,18(1):34-35. 被引量:1
  • 2姚光弼.关注我国自身免疫性肝炎的诊断和治疗[J].中华肝脏病杂志,2005,13(1):1-2. 被引量:23
  • 3周建明 董学林.老年人自身免疫性肝炎[J].日本医学介绍,1998,19:322-322.
  • 4Manns MP.Hepatotropic Viruses and Autoimmunity 1997[J].Journal of Viral Hepatitis,1997,4(suppl 1):7-10
  • 5Prandota J.Possible Pathomechanism of Autoimmune Hepatitis[J].American Journal of Therapeutics,2003,10(1):51-57
  • 6Obermayer-straub P,Strassburg CP,Manns MP.Autoimmune Hepatitis[J].Journal of Hepatology,2000,32(1):181-197
  • 7Garcia-Buey L,Garcia-Monzon C,Rodriguez S,et al.Latent Autoimmune Hepatitis Triggered during Interferon Therapy in Patients with Chronic Hepatitis C[J].Gastroenterology,1995,108(6):1770-1777
  • 8Czaja AJ,Sievers C,Zein NN.Nature and Behavior of Immunoregulatory Cytokines in Type 1 Autoimmune Hepatitis[J].Gastroenterology,1999,116:A1199
  • 9Qiu Dk,Ma X Relationship between Human teukocyte Antigen-DRB1 and Autoimmune Hepatitis Type I in Chinese Patients[J].Journal of Gastroenterology and Hepatology,2003,18(1):63-67
  • 10Medina J,Garcia-Buey L,Moreno-Otero R Review Article:Immunopathogenetic and Therapeutic Aspects of Autoimmune Hepatitis[J].Alimentary Pharmacology and Therapeutics,2003,17(1):1-16

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部